Hersh et al. identified that Fn14 was overexpressed in patient-derived xenograft cell lines isolated from recurrent glioblastoma and gliosarcomas in comparison with nonneoplastic brain tissues and primary glioblastomas. This evidence concerns the gene TNFRSF12A and gliosarcoma.